Level Bio AB (publ) (NGM:LEVBIO)
0.3300
+0.0220 (7.14%)
At close: Sep 15, 2025
Level Bio AB Market Cap
Level Bio AB has a market cap or net worth of 22.57 million as of September 16, 2025. Its market cap has decreased by -5.81% in one year.
Market Cap
22.57M
Enterprise Value
21.01M
Revenue
30.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.33
Market Cap Chart
Since September 18, 2006, Level Bio AB's market cap has decreased from 35.14M to 22.57M, a decrease of -35.77%. That is a compound annual growth rate of -2.30%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 15, 2025 | 22.57M | 19.57% |
Dec 30, 2024 | 18.88M | -27.02% |
Dec 29, 2023 | 25.87M | -45.31% |
Dec 30, 2022 | 47.30M | -70.97% |
Dec 30, 2021 | 162.94M | 142.83% |
Dec 30, 2020 | 67.10M | 284.85% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Investor AB | 875.09B |
Atlas Copco AB | 739.10B |
AB Volvo | 556.31B |
EQT AB | 391.53B |
ASSA ABLOY AB | 377.11B |
Skandinaviska Enskilda Banken AB | 355.92B |
Sandvik AB | 313.60B |
Swedbank AB | 308.60B |